{"version":"1.0","provider_name":"Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare","provider_url":"https:\/\/ceptonstrategies.com\/en","author_name":"Marc-Olivier B\u00e9vierre","author_url":"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/","title":"COVIDNews CEPTON-INATO #1 &#8211; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"hcr4rvVu6s\"><a href=\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\">COVIDNews CEPTON-INATO #1<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/embed\/#?secret=hcr4rvVu6s\" width=\"600\" height=\"338\" title=\"&#8220;COVIDNews CEPTON-INATO #1&#8221; &#8212; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare\" data-secret=\"hcr4rvVu6s\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","thumbnail_width":3500,"thumbnail_height":2333,"description":"Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON\u00a0and\u00a0INATO\u00a0will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the \u00a0ANTICOVID \u00a0data. By Allan Beke, Phd,\u00a0Matthias Bucher with the support of Inato team"}